Literature DB >> 8903115

Different binding of 125I-LPS to plasma proteins from persons with high or low HDL.

J B Eggesbø1, T Lyberg, T Aspelin, I Hjermann, P Kierulf.   

Abstract

In severe trauma, sepsis or during surgery, bacterial lipopolysaccharide (LPS) frequently enters the circulation. Persons with high levels of high-density lipoprotein (HDL) have previously demonstrated higher monocyte procoagulant activity (PCA) when whole blood is challenged with LPS. The aim of the study was to investigate the distribution of radiolabelled LPS (125I-LPS) in plasma from six persons with high (2.14-2.82 mmol l-1) and six persons with low (0.54-1.04 nmol l-1) HDL, subjecting plasma to fast protein liquid chromatography (FPLC), or agarose electrophoresis followed by quantitative autoradiography. In heparin plasma 125I-LPS was located mainly in parts of plasma containing low-density lipoprotein (LDL) or very low-density lipoprotein (VLDL) and the immunoglobulins, and located to a lesser extent in HDL. However, persons with high HDL showed significantly higher binding of 125I-LPS to HDL and the immunoglobulins, probably to IgG, and significantly lower binding to LDL/VLDL. In calcium-depleted plasma (EDTA) 125I-LPS demonstrated a sharp increase in the binding to HDL, combined with a persistently high binding to LDL/VLDL and binding to the immunoglobulins was almost eliminated in all subjects investigated. Likewise, the binding of 125I-LPS to HDL in EDTA plasma was also significantly higher and to LDL/VLDL significantly lower in persons with high HDL. This study demonstrates that the distribution of 125I-LPS in heparin and EDTA plasma from persons with high or low HDL is different, which is presumed to be of importance concerning the various bioactivities of LPS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903115     DOI: 10.3109/00365519609088809

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  11 in total

1.  Distribution and kinetics of lipoprotein-bound endotoxin.

Authors:  J H Levels; P R Abraham; A van den Ende; S J van Deventer
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood.

Authors:  H J van Leeuwen; M Van Der Tol; J A G Van Strijp; J Verhoef; K P M van Kessel
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

3.  Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.

Authors:  J H M Levels; J A Marquart; P R Abraham; A E van den Ende; H O F Molhuizen; S J H van Deventer; J C M Meijers
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 4.  Regulation of macrophage function in inflammation and atherosclerosis.

Authors:  Norihito Shibata; Christopher K Glass
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

Review 5.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

6.  LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.

Authors:  A C Vreugdenhil; A M Snoek; C van 't Veer; J W Greve; W A Buurman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

7.  Distribution and kinetics of lipoprotein-bound lipoteichoic acid.

Authors:  Johannes H M Levels; Philip R Abraham; Erik P van Barreveld; Joost C M Meijers; Sander J H van Deventer
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

8.  Acute phase protein response and changes in lipoprotein particle size in dogs with systemic inflammatory response syndrome.

Authors:  Erica Behling-Kelly; Carol E Haak; Patrick Carney; Jessica Waffle; Kelly Eaton; Robert Goggs
Journal:  J Vet Intern Med       Date:  2022-04-14       Impact factor: 3.175

9.  An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test.

Authors:  Stephan Harm; Claudia Schildböck; Karin Strobl; Jens Hartmann
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 10.  HDL in sepsis - risk factor and therapeutic approach.

Authors:  Emily E Morin; Ling Guo; Anna Schwendeman; Xiang-An Li
Journal:  Front Pharmacol       Date:  2015-10-23       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.